Oxford – Communicable Diseases Research

Longitudinal survey of humoral and cellular response to SARS-CoV-2 infection in children

Article

Published on 2022-11-012022-11-15
Journal: Microbiological research
[Category] COVID19(2023년), SARS, 진단, 치료기술,

An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients

Article

Published on 2022-10-052022-11-16
Journal: eLife
[Category] COVID19(2023년), SARS, 변종,

[키워드] adjusted Analysis analysis Appendix approach assumption available data Calabria carrier caused changes in characterisation clinical Clinical outcome Clinical research clinical study collected Commonwealth confidence interval confounders COVID-19 dataset DAVID development Donor emergence Epidemiology European European Commission fatality Foreign foundation Frequency funding global health Google.org group heterogeneity Horizon hospital hospitalised hospitalised patient Imperial College London include infecting Infection Infectious disease International IRCCS ISARIC Italian Joshua less Logistic regression lower mortality Medical Research Council Medicine Melinda Gate Microbiology Ministry of Health network NIHR NIHR HPRU Odds ratio office omicron opportunity outcome Oxford Patient PHE protection Public Health England Rapid relative frequencies reported symptom Research respiratory response responsible Rockefeller Foundation SARS-CoV-2 variant School Semple sensitivity analysis Sriniva study population subset Support supported Symptoms union unit University of Liverpool University of Oxford variant variants viral genomic information viruses viruses. with COVID-19
[DOI] 10.7554/eLife.80556 PMC 바로가기

SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants

Article

Published on 2022-10-032022-11-15
Journal: Frontiers in Immunology
[Category] COVID19(2023년), SARS, 진단,

[키워드] addition adenovirus vaccine Analysis anti-SARS-CoV-2 IgG Anti-spike AstraZeneca BBIBP-CorV Blood Breastfeeding breastmilk ChAdOx1-S children Cohort convalescent COVID-19 COVID-19 vaccine cross-sectional decrease eligible evaluated IgA IgA level IgA response IgG IgG level immune response immune response. inactivated Infection information lactating lactating women mother mRNA naïve Newborn no significant difference Oxford participant passive immunity positive receive receiving recent SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine SARS-CoV-2-specific antibody second dose serum serum sample shown significantly higher Sinopharm Sputnik V vaccination Vaccine vaccine platform Vaccines women
[DOI] 10.3389/fimmu.2022.909995 PMC 바로가기

MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature

Article

Published on 2022-10-012022-11-15
Journal: Journal of Neurology
[Category] COVID19(2023년), SARS, 진단, 치료기술,

[키워드] acute respiratory syndrome Adults affected analysed antibody AstraZeneca attack available data AZD1222 blindness BNT162b2 booster vaccination Brain Brainstem Brainstem encephalitis Case report cerebrospinal fluid ChAdOx1 ChAdOx1 nCoV-19 ChAdOx1-S CNS complete recovery coronavirus Coronavirus disease 2019 Coronavirus disease 2019 (COVID-2019) COVID-19 CSF detectable disease dysfunction Encephalitis epidemiological Escalation exceeded female first dose functional glycoprotein IgG1 immunization Immunoglobulin Immunotherapy laboratory feature Longitudinally extensive transverse myelitis (LETM) majority male median median age median interval MOG MOG antibodies (MOG-IgG) mRNA vaccine mRNA-1273 mRNA-1273. much lower Myelin Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) Myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis (MOG-EM) Myelitis Neuromyelitis Optica Neuromyelitis optica spectrum disorders occur occurred Optic Optic neuritis Oxford paraplegia Patient patients patients with SARS-CoV-2 Pfizer phenotype plasma Postinfectious Postvaccinal predominant radiological remained required residual symptom SARS-CoV2 serum Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) severity steroid treatment therapy Treatment Treatment outcome vaccination Vaccine WCC white cell
[DOI] 10.1007/s00415-022-11194-9 PMC 바로가기

Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19

Research article

Published on 2022-10-012022-10-05
Journal: International Journal of Environmental Research an
[Category] COVID19(2023년), SARS, 바이오마커, 변종, 유전자 메커니즘, 임상, 진단, 치료기술,

[키워드] 95% CI Activation adjusted adjusted odds ratio aggregation Alpha Analysis application B.1.1.7 Bath biochemical Biomarkers biomarkers of inflammation biopsy changes clinical factors clinical outcomes clinically Coagulation Cohort Complication correlation Council COVID-19 death develop Dexamethasone diagnostic Direct driving dysregulation of coagulation Engineering evaluated facilitate finding foundation funding hazard ratio heart hospital identify in-hospital mortality indicated Inflammation investigated mammary marker myocardial injury National Health Service NHS NIHR Non-invasive outcome Oxford parameters Pathways Patient patients with COVID-19 perivascular Platelet platform predict produced Prognostic value pulmonary angiography pulmonary CT representing respond responsible risk RNA sequencing data SARS-CoV-2 variant Science sensitivity analysis targeted therapy therapeutic target transcriptional transcriptomic Treatment Trial validation study variant vascular inflammation Wellcome Trust Whole blood wild-type SARS-CoV-2 with COVID-19
[DOI] 10.1016/S2589-7500(22)00132-7 [Article Type] Research article

Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients

Article

Published on 2022-10-012022-11-16
Journal: The lancet. Psychiatry
[Category] COVID19(2023년), SARS, 변종,

[키워드] 1:1 Adults Affect age Alpha Analysis Anxiety Anxiety Disorder B.1.1.529 B.1.1.7 B.1.617.2 baseline Brain Bulgaria children cognitive Cohort cohort of patient cohorts cohorts of patient collected COVID-19 death rate Dementia Demographic factors diagnose diagnosed diagnosed with COVID-19 Diagnosis diagnosis of COVID-19 died disorder disorders Electronic health record epilepsy female Follow-up follow-up period foundation greater hazard ratio health-care health-care system help higher risk hospital HRs incidence increased risk India indicate individual Insomnia International ischaemic stroke less Malaysia male matching neurological Older other respiratory infections outcome outcomes Oxford Parkinsonism Pathogenesis Patient primary care profile proportion Psychiatric psychiatric diagnose psychiatric diagnosis psychiatric disorder reached recorded remained representing respiratory infection response retrospective cohort retrospective cohort study returned risk risk factor SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant Seizure Seizures severe COVID-19 illness significantly Spain stratified study period sustained Taiwan trajectory USA vaccination variant variants was done while with COVID-19 Wolfson
[DOI] 10.1016/S2215-0366(22)00260-7 PMC 바로가기

Reliability of multi-site UK Biobank MRI brain phenotypes for the assessment of neuropsychiatric complications of SARS-CoV-2 infection: The COVID-CNS travelling heads study

Article

Published on 2022-09-292022-11-16
Journal: PLoS ONE
[Category] SARS, 유전자 메커니즘,

Tracking SARS-COV-2 variants using Nanopore sequencing in Ukraine in 2021

Article

Published on 2022-09-212022-11-16
Journal: Scientific Reports
[Category] SARS, 변종,

COVID-19 in Africa: Underreporting, demographic effect, chaotic dynamics, and mitigation strategy impact

Article

Published on 2022-09-162022-11-16
Journal: PLoS Neglected Tropical Diseases
[Category] SARS, 변종, 치료기술,

Genomics of postvaccination SARS-CoV-2 infections during the Delta dominated second wave of COVID-19 pandemic, from Mumbai Metropolitan Region (MMR), India

델타가 인도 뭄바이 대도시 지역(MMR)에서 발생한 COVID-19 대유행의 두 번째 물결을 지배하는 동안 백신 접종 후 SARS-CoV-2 감염의 게놈

Article

Published on 2022-09-012022-09-11
Journal: Journal of medical virology
[Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 치료법,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analyzed association B.1.617.2 clade collected coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 pandemic COVID-19 patient Delta delta variant Delta+ demographics disease severity Epidemiology form genetics Genomics Home isolation hospital increase in India Infection initiated K417N Lineage lineages MMR Mumbai Mutation mutations nanopore sequencing nucleocapsid ORF1a Oxford Patient postvaccination predominant progressed proportion reduction in Region Sample SARS Coronavirus SARS-CoV-2 SARS-COV-2 infection second wave selected sequence sequenced sequences severe acute respiratory syndrome Coronavirus shown the disease vaccination Vaccination Status variant viral genome viral genomes virus virus classification virus classification. Wave
[DOI] 10.1002/jmv.27861 PMC 바로가기 [Article Type] Article